The recruitment of patients into clinical trials.
作者信息
Tannock I F
出版信息
Br J Cancer. 1995 Jun;71(6):1134-5. doi: 10.1038/bjc.1995.221.
Abstract
摘要
相似文献
1
The recruitment of patients into clinical trials.将患者纳入临床试验。
Br J Cancer. 1995 Jun;71(6):1134-5. doi: 10.1038/bjc.1995.221.
2
Reliable evidence of safety and efficacy of elderly patients in randomized clinical trials still needed.仍需要在随机临床试验中获得老年患者安全性和有效性的可靠证据。
J Clin Oncol. 2007 Sep 1;25(25):4027-8; author reply 4028. doi: 10.1200/JCO.2007.12.8595.
3
Clinical trial design in oncology: selection of patients.
Lancet Oncol. 2004 Dec;5(12):760.
4
Restructuring cancer clinical trials.
J Am Coll Radiol. 2005 Oct;2(10):816-7. doi: 10.1016/j.jacr.2005.07.005.
5
Response to Hadorn et al on increasing recruitment into randomised clinical trials.对哈多恩等人关于增加随机临床试验入组人数的回应。
N Z Med J. 2013 Sep 27;126(1383):104-6.
6
Clinicians' attitudes to recruitment to randomised trials in cancer care: a qualitative study.临床医生对癌症护理中随机试验招募工作的态度：一项定性研究。
J Health Serv Res Policy. 2000 Jul;5(3):164-9. doi: 10.1177/135581960000500307.
7
Design of cancer screening trials/randomized trials for evaluation of cancer screening.用于评估癌症筛查的癌症筛查试验/随机试验设计
World J Surg. 2006 Jul;30(7):1152-62. doi: 10.1007/s00268-006-0074-9.
8
[Phases 0, 1 and 2 oncology clinical trials: current questions].[肿瘤学0期、1期和2期临床试验：当前问题]
Bull Cancer. 2010 Jan;97(1):55-63. doi: 10.1684/bdc.2010.1016.
9
Poor recruitment to lung cancer trials.肺癌试验的招募情况不佳。
BMJ. 1997 Mar 29;314(7085):974-5. doi: 10.1136/bmj.314.7085.974a.
10
Oncologist's role critical to clinical trial enrollment.肿瘤学家在临床试验入组方面的作用至关重要。
J Natl Cancer Inst. 2000 Oct 18;92(20):1632-4. doi: 10.1093/jnci/92.20.1632.
引用本文的文献
1
A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomized controlled trials in palliative care.一项关于姑息治疗医护人员对于转诊癌症患者以参与姑息治疗随机对照试验的观点的调查。
Support Care Cancer. 2008 Dec;16(12):1397-405. doi: 10.1007/s00520-008-0441-1. Epub 2008 May 1.
2
Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy.围绕参与癌症化疗I期和II期临床试验的患者动机。
Br J Cancer. 2005 Mar 28;92(6):1001-5. doi: 10.1038/sj.bjc.6602423.
本文引用的文献
1
A decade of breast cancer clinical investigation: results as reported in the Program/Proceedings of the American Society of Clinical Oncology.十年乳腺癌临床研究：美国临床肿瘤学会会议议程/论文集所报告的结果
J Clin Oncol. 1994 Sep;12(9):1789-95. doi: 10.1200/JCO.1994.12.9.1789.
2
Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer.医生不将符合条件的患者纳入乳腺癌手术随机临床试验的原因。
N Engl J Med. 1984 May 24;310(21):1363-7. doi: 10.1056/NEJM198405243102106.
3
Equipoise and the ethics of clinical research.equipoise与临床研究伦理
N Engl J Med. 1987 Jul 16;317(3):141-5. doi: 10.1056/NEJM198707163170304.
4
Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment.癌症临床试验：替代患者在界定何为符合伦理道德的可接受临床试验方面的作用。
Br J Cancer. 1989 Mar;59(3):388-95. doi: 10.1038/bjc.1989.78.
5
Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria.随机对照试验的患者选择：宽泛或严格入选标准的影响
Stat Med. 1990 Jan-Feb;9(1-2):73-83; discussion 83-6. doi: 10.1002/sim.4780090114.
6
Are treatment strategies of urologic oncologists influenced by the opinions of their colleagues?泌尿外科肿瘤学家的治疗策略会受到同事意见的影响吗？
Br J Cancer. 1990 Dec;62(6):988-91. doi: 10.1038/bjc.1990.422.
7
AXIS--a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee.AXIS——一个适合治疗的病例。英国癌症研究协调委员会（UKCCCR）结直肠癌小组委员会。
Br J Cancer. 1991 Jun;63(6):841-5. doi: 10.1038/bjc.1991.187.
8
Redressing the balance--the ethics of not entering an eligible patient on a randomised clinical trial.
Ann Oncol. 1992 Feb;3(2):103-5. doi: 10.1093/oxfordjournals.annonc.a058119.
Zotero 插件